Active Ingredient History
Streptococcus salivarius is a species of spherical, gram-positive, facultative anaerobic lactic acid bacteria that is both catalase and oxidase negative. S. salivarius colonizes the oral cavity and upper respiratory tract of humans just a few hours after birth, making further exposure to the bacteria harmless in most circumstances. The bacterium is considered an opportunistic pathogen, rarely finding its way into the bloodstream, where it has been implicated in cases of sepsis in people with neutropenia,. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Acute-On-Chronic Liver Failure (Phase 2/Phase 3)
Adenomatous Polyposis Coli (Phase 2)
Ascites (Phase 2)
Crohn Disease (Phase 4)
Deglutition Disorders (Early Phase 1)
Diarrhea (Phase 2/Phase 3)
Drug Resistance, Bacterial (Phase 2)
Fatty Liver (Phase 1)
Halitosis (Phase 2)
Hepatic Encephalopathy (Phase 3)
Hirschsprung Disease (Phase 2)
Inflammatory Bowel Diseases (Phase 3)
Intestinal Neoplasms (Early Phase 1)
Irritable Bowel Syndrome (Phase 4)
Klebsiella pneumoniae (Phase 1/Phase 2)
Liver Cirrhosis (Phase 2/Phase 3)
Osteoporosis (Phase 2)
Peritonitis (Phase 2/Phase 3)
Probiotics (Phase 4)
Squamous Cell Carcinoma of Head and Neck (Phase 2)
Tongue Diseases (Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
